Latest Schedule 13G passive stakes

State Street Corporation and SSGA Funds Management, Inc. have reported beneficial ownership of 10.2% and 8% respectively in Centrus Energy Corp. common stock.

State Street Corporation and SSGA Funds Management, Inc. have reported beneficial ownership of 10.2% and 8% respectively in Centrus Energy Corp. common stock.

FMR LLC and Abigail P. Johnson have jointly filed an amended Schedule 13G, disclosing beneficial ownership of 1.4% of Tenax Therapeutics Inc.'s common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 10.2% in Charles River Laboratories International, Inc. as of August 31, 2026.

FMR LLC and Abigail P. Johnson have filed a Schedule 13G, reporting beneficial ownership of 10.6% of Graphic Packaging Holding Co.'s common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 12.7% of Onterris Inc.'s common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing to reflect beneficial ownership of 11.0% of Viatris Inc.'s common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing, reporting a combined beneficial ownership of 5.7% in Lenz Therapeutics Inc. as of August 31, 2026.

FMR LLC, along with Abigail P. Johnson, has reported a beneficial ownership of 10.4% in Covista Inc.'s common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 3.7% of Luxfer Holdings PLC's common stock as of August 31, 2026.

FMR LLC, along with Abigail P. Johnson, has reported a beneficial ownership of 13.2% of Twist Bioscience Corp.'s common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 10.2% of Blue Bird Corp's common stock as of August 31, 2026.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 11.0% in Resideo Technologies Inc. common stock as of August 31, 2026.

FMR LLC, along with Abigail P. Johnson, has reported a beneficial ownership of 4.1% in Bowman Consulting Group Ltd's common stock as of August 31, 2026.

FMR LLC, along with Abigail P. Johnson, has increased its beneficial ownership of SunocoCorp LLC's common stock to 10.9%, holding 5,632,345 shares.

FMR LLC, through its affiliates, now beneficially owns 10.6% of ADI Global Distribution Inc.'s common stock, as reported in a Schedule 13G filing.

FMR LLC and Abigail P. Johnson have filed a Schedule 13G, reporting a minimal beneficial ownership of Leggett & Platt Inc. common stock.

FMR LLC and Abigail P. Johnson have filed a Schedule 13G, reporting 0.00 shares beneficially owned in Orla Mining Ltd as of August 31, 2026.

The Lincoln National Life Insurance Company has filed a Schedule 13G, reporting beneficial ownership of 640,000 Series H Mandatory Redeemable Preferred Shares in Calamos Strategic Total Return Fund.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 9.2% in Revvity Inc. common stock.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7.5% of BioLife Solutions Inc.'s common stock as of August 31, 2026.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 13,492,736 shares of Teamshares Inc. common stock, representing 18.3% of the class.

Frontier Nuclear & Minerals Inc. has disclosed a beneficial ownership of 9.9% in Nuran Wireless Inc., comprising directly held shares and potential shares from warrant exercise.

Frontier Nuclear & Minerals Inc. has disclosed a beneficial ownership of 9.9% in Nuran Wireless Inc., comprising directly held shares and potential shares from warrant exercise.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 12.8% of Vicor Corp's common stock.

T. Rowe Price Associates, Inc. has updated its Schedule 13G filing, reporting beneficial ownership of Perrigo Co PLC's common stock.

T. Rowe Price Associates, Inc. has reported beneficial ownership of 8.8% of iQIYI Inc.-ADR, holding over 83.9 million shares.

T. Rowe Price Associates, Inc. has reported beneficial ownership of 14,044,020 shares, representing 11.7% of the class, in 10X Genomics Inc. Class A common stock.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 10.7% of Kymera Therapeutics' common stock as of August 31, 2026.

T. Rowe Price Associates, Inc. has reported a beneficial ownership of 3,940,556 shares, representing 8.7% of the outstanding common stock of Midera Food Processi Inc.